|
|
Article: Biotech Holdings leases facilities, acquires equipment for Sucanon drug production.
- Article from:
- PR Newswire
- Article date:
- January 28, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Robert Rieveley, President of Biotech Holdings (the "Company", BIOHF.OB: OB; BIO.V) announced today that the Company has completed lease arrangements for a facility where Sucanon, the Company's treatment for Type II Diabetes symptoms, will be produced.
"I am pleased to announce that we now have acquired facilities and have completed the acquisition of most of the necessary laboratory equipment and production machinery for scale-up of commercial production of Sucanon. We plan to carry out synthesis, extraction and pre-mixing in Vancouver. Pre-mix powder will then be sent to Mexico for tableting, coating, packaging and delivery to our marketers," Mr. Rieveley ...
Related newspaper, magazine, and journal articles:
|
|
Article: Biotech Holdings expands distribution of its ...
PR Newswire;
May 30, 2007 ;
700+ words
... ... growth in these new markets, Biotech Holdings will transfer to the Colombian ... the Board of Directors of Biotech Holdings. The TSX Venture Exchange does not accept ... wish to be removed from Biotech Holdings' email news distribution ...
|
|